Evidence map›Paper›PMID 41809611›Full record

ArticleSultan Qaboos University medical journal2026

Genetic Analysis and Clinical Effect of

Shaimaa Y Abdulfattah, Sumaya Saady

Abstract read
In one paragraph

Article in Sultan Qaboos University medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shaimaa Y AbdulfattahMedical and Molecular Department, Biotechnology Research Center, Al-Nahrain University, Baghdad, Iraq.ORCID 0000-0001-6979-9955
Sumaya SaadyMedical and Molecular Department, Biotechnology Research Center, Al-Nahrain University, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to investigate the association of two intronic polymorphisms of the Methods: This case-control study was conducted from March to September 2023 at the Iraqi Center of Heart Disease, Baghdad, Iraq, and included patients with CAD and dyslipidaemia. Genotyping was performed using TaqMan probes and real-time qPCR. Results: A total of 170 participants were included in this study. Demographic, echocardiographic, and lipid profile data were analysed, revealing significant differences in age, left ventricular ejection fraction %, LV systolic diameter, LV diastolic diameter and lipid parameters. The T-allele of rs2285666 was significantly associated with CAD risk in both females (odds ratio [OR] = 2.06, 95% confidence interval [CI]: 1.06-4; Conclusion: The T-allele of rs2285666 and the G-allele of rs4646188 were identified as potential risk factors for CAD in both sexes, with their effects influenced by dyslipidaemia status.

Indexed as

Angiotensin-Converting Enzyme 2Coronary Artery DiseaseDyslipidemiasPeptidyl-Dipeptidase AAdultCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansIraqMaleMiddle AgedPolymorphism, Single NucleotideRisk FactorsACE2 protein, humanAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AAngiotensin-Converting EnzymeCoronary Artery DiseaseDyslipidemiaGenetic PolymorphismIraq

Identifiers

PMID41809611
PMCPMC12969405

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.